- Home
- RMBI vs BDTX Comparison
RMBI vs BDTX Comparison
Compare RMBI & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMBI | BDTX |
|---|---|---|
| Founded | 1887 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.8M | 148.1M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RMBI | BDTX |
|---|---|---|
| Price | $13.98 | $2.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.60 |
| AVG Volume (30 Days) | 24.4K | ★ 1.6M |
| Earning Date | 01-22-2026 | 11-06-2025 |
| Dividend Yield | ★ 4.29% | N/A |
| EPS Growth | ★ 21.88 | N/A |
| EPS | ★ 1.06 | 0.38 |
| Revenue | $44,970,551.00 | ★ $70,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.21 | ★ $6.75 |
| Revenue Growth | ★ 6.42 | N/A |
| 52 Week Low | $11.37 | $1.20 |
| 52 Week High | $15.24 | $4.94 |
Technical Indicators
Market Signals| Indicator | RMBI | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.49 | 36.93 |
| Support Level | $14.01 | $2.52 |
| Resistance Level | $14.48 | $2.65 |
| Average True Range (ATR) | 0.32 | 0.15 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 52.22 | 51.87 |
Price Performance
Historical ComparisonAbout RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.